Efficacy and safety of different dual antiplatelet strategies in patients undergoing percutaneous coronary intervention: A systematic review and network meta‐analysis
Abstract Background Dual antiplatelet therapy (DAPT) is key for preventing ischaemic events post‐percutaneous coronary intervention (PCI). Various DAPT modifications like the shortened duration or P2Y12 inhibitor (P2Y12i) de‐escalation are implemented to reduce bleeding risk. However, these strategi...
Main Authors: | Yuttana Wongsalap, Kirati Kengkla, Preyanate Wilairat, Khemanat Ratworawong, Surasak Saokaew, Chaisiri Wanlapakorn |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-12-01
|
Series: | Chronic Diseases and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cdt3.85 |
Similar Items
-
Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how
by: Marie Muthspiel, et al.
Published: (2022-11-01) -
De-escalation versus standard dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
by: Chen Guo, et al.
Published: (2020-01-01) -
De-escalation of antiplatelet therapy in acute coronary syndromes: Why, how and when?
by: Mattia Galli, et al.
Published: (2022-08-01) -
Efficiency and safety of various dual antiplatelet therapy strategies in patients undergoing percutaneous coronary intervention due to myocardial infarction
by: S. B. Aksentiev, et al.
Published: (2021-08-01) -
Effectiveness of dual antiplatelet de-escalation therapy on the prognosis of patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention
by: Zhigang Zhao, et al.
Published: (2023-03-01)